Searchable abstracts of presentations at key conferences in endocrinology

ea0032p124 | Calcium and Vitamin D metabolism | ECE2013

Serum sclerostin and Dkk1 in patients with parathyroid disorders

Viccica Giuseppe , Borsari Simona , Pardi Elena , Chiavistelli Silvia , Albertini Sonia , Centoni Roberta , Cetani Filomena , Marcocci Claudio

The ‘canonical’ Wnt/β-catenin pathway plays an important role in the development and patterning of bone. Dkk1 (Dickkopf1) and sclerostin are competitive soluble inhibitors of this pathway. Serum sclerostin is decreased in patients with primary hyperparathyroidism (PHPT) compared to the healthy subjects and hypoparathyroid (HypoPT) patients. No data are currently available on Dkk1 serum level in PHPT.We evaluated serum Dkk1 and sclerostin l...